Hertl M - Search Results

1

Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial.

van Beek N, Eming R, Reuss A, Zillikens D, Sárdy M, Günther C, Kiritsi D, Benoit S, Beissert S, Gläser R, Gollnick H, Horváth ON, Pfeiffer C, Röcken M, Schauer F, Schreml S, Steinbrink K, Zink A, Schade-Brittinger C, Hertl M, Schmidt E. van Beek N, et al. Among authors: hertl m. Br J Dermatol. 2024 Apr 17;190(5):657-667. doi: 10.1093/bjd/ljad489. Br J Dermatol. 2024. PMID: 38133541 Clinical Trial.

2

[Significant decrease in quality of life in patients with pemphigus vulgaris. Results from the German Bullous Skin Disease (BSD) Study Group].

Mayrshofer F, Hertl M, Sinkgraven R, Sticherling M, Pfeiffer C, Zillikens D, Messer G, Rzany Für Die Deutschebsd-Studiengruppe B. Mayrshofer F, et al. Among authors: hertl m. J Dtsch Dermatol Ges. 2005 Jun;3(6):431-5. doi: 10.1111/j.1610-0387.2005.05722.x. J Dtsch Dermatol Ges. 2005. PMID: 15892845 German.

3

[The use of high dose intravenous immunoglobulins in dermatology].

Enk A, Hertl M, Messer G, Meurer M, Rentz E, Zillikens D. Enk A, et al. Among authors: hertl m. J Dtsch Dermatol Ges. 2003 Mar;1(3):183-90. doi: 10.1046/j.1610-0387.2003.02028.x. J Dtsch Dermatol Ges. 2003. PMID: 16285493 German.

4

Autoimmune bullous disorders.

Eming R, Hertl M; Autoimmune Diagnostics Working Group. Eming R, et al. Among authors: hertl m. Clin Chem Lab Med. 2006;44(2):144-9. doi: 10.1515/CCLM.2006.027. Clin Chem Lab Med. 2006. PMID: 16475898 Free article. Review.

5

Prolonged clinical remission of patients with severe pemphigus upon rapid removal of desmoglein-reactive autoantibodies by immunoadsorption.

Eming R, Rech J, Barth S, Kalden JR, Schuler G, Harrer T, Hertl M. Eming R, et al. Among authors: hertl m. Dermatology. 2006;212(2):177-87. doi: 10.1159/000090659. Dermatology. 2006. PMID: 16484825

6

T cell control in autoimmune bullous skin disorders.

Hertl M, Eming R, Veldman C. Hertl M, et al. J Clin Invest. 2006 May;116(5):1159-66. doi: 10.1172/JCI28547. J Clin Invest. 2006. PMID: 16670756 Free PMC article. Review.

7

Immunoadsorption in pemphigus.

Eming R, Hertl M. Eming R, et al. Among authors: hertl m. Autoimmunity. 2006 Nov;39(7):609-16. doi: 10.1080/08916930600972040. Autoimmunity. 2006. PMID: 17101505 Review.

8

Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DR beta 1*0402 tetramers.

Veldman C, Eming R, Wolff-Franke S, Sonderstrup G, Kwok WW, Hertl M. Veldman C, et al. Among authors: hertl m. Clin Immunol. 2007 Mar;122(3):330-7. doi: 10.1016/j.clim.2006.09.014. Epub 2006 Nov 17. Clin Immunol. 2007. PMID: 17113829

9

Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies).

Niedermeier A, Eming R, Pfütze M, Neumann CR, Happel C, Reich K, Hertl M. Niedermeier A, et al. Among authors: hertl m. Arch Dermatol. 2007 Feb;143(2):192-8. doi: 10.1001/archderm.143.2.192. Arch Dermatol. 2007. PMID: 17309999

10

Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigus.

Pfütze M, Niedermeier A, Hertl M, Eming R. Pfütze M, et al. Among authors: hertl m. Eur J Dermatol. 2007 Jan-Feb;17(1):4-11. doi: 10.1684/ejd.2007.0090. Epub 2007 Feb 27. Eur J Dermatol. 2007. PMID: 17324820 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

502 results

Search Page